Evidence map›Paper›PMID 24388790›Full record

ReviewTrends in pharmacological sciences2014

Regulation of transcription factor activity by interconnected post-translational modifications.

Theresa M Filtz, Walter K Vogel, Mark Leid

Open access · greenAbstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 232 citations in OpenAlex.

  1. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Probing transcription factor subsets in gene regulatory networks.Algorithms for molecular biology : AMB · 2026
    Article
  11. Article
  12. Article
  13. Reprogramming of neuronal genome function and phenotype by astrocytes.bioRxiv : the preprint server for biology · 2026
    Article
  14. Article
  15. Oxidized LDL Induces Pro-Inflammatory Transcriptomic and Epigenomic Responses in Human CD4FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Theresa M FiltzDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR 97331, USA. Electronic address: theresa.filtz@oregonstate.edu.
Walter K VogelDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR 97331, USA.
Mark LeidDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR 97331, USA; Department of Integrative Biosciences, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: mark.leid@oregonstate.edu.
Oregon State University · US

Funding

Bcl11b transcription factor regulation by phosphorylation and sumoylationR15GM096243 · NIGMS · OREGON STATE UNIVERSITY · PI FILTZ, THERESA MARIE · 2011 to 2011
$292k
The Ctip2/Bcl11b transcriptional network in tooth developmentR15DE021879 · NIDCR · OREGON STATE UNIVERSITY · PI LEID, MARK E · 2011 to 2011
$291k
NIDCR NIH HHS DE021879NIDCR NIH HHS R15 DE021879NIGMS NIH HHS GM096243NIGMS NIH HHS R15 GM096243
6 · The paper itself

Abstract

Transcription factors comprise just over 7% of the human proteome and serve as gatekeepers of cellular function, integrating external signal information into gene expression programs that reconfigure cellular physiology at the most basic levels. Surface-initiated cell signaling pathways converge on transcription factors, decorating these proteins with an array of post-translational modifications (PTMs) that are often interdependent, being linked in time, space, and combinatorial function. These PTMs orchestrate every activity of a transcription factor over its entire lifespan--from subcellular localization to protein-protein interactions, sequence-specific DNA binding, transcriptional regulatory activity, and protein stability--and play key roles in the epigenetic regulation of gene expression. The multitude of PTMs of transcription factors also offers numerous potential points of intervention for development of therapeutic agents to treat a wide spectrum of diseases. We review PTMs most commonly targeting transcription factors, focusing on recent reports of sequential and linked PTMs of individual factors.

Indexed as

Protein Processing, Post-TranslationalAnimalsHumansProteinsTranscription FactorsProteinsTranscription Factors

Identifiers

PMID24388790
PMCPMC3954851
OpenAlexW1978279515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.